Director of Regulatory Filings

Kelly Hoy joined the Diffusion team in February 2004. She has over twenty years experience in the drug development industry having held many positions. As Diffusion’s Regulatory Filings Director, she manages all Company regulatory submissions and documentation including trial master files and standard operating procedures. She coordinates the writing, assembling, and filing of the Company’s Investigational New Drug (IND) Applications and all subsequent amendments ensuring all federal guidelines are followed and receives Food and Drug Administration (FDA) approval. She serves as the main point of contact for the FDA to facilitate activities that satisfy their needs to move the Company’s clinical program forward.